General
Novo Nordisk names new CEO amid share price slump and concerns over Wegovy, Ozempic sales
Danish pharmaceutical giant Novo Nordisk, known for its weight-loss drugs Wegovy and Ozempic, has named Maziar Mike Doustdar as its new chief executive, relying on an experienced company insider to make up ground lost to market rivals.
Mr Doustdar’s appointment came on Tuesday after the abrupt…
Continue Reading
-
Noosa News18 hours agoTeachers strike looms as thousands prepare to walk off the job next Wednesday in Queensland
-
Noosa News20 hours agoWinds force Gilmour Space to cancel historic Queensland rocket launch
-
Noosa News22 hours agoMan jailed for decade-long $1.7 million extortion of former lover
-
General21 hours agoHobart City Council pursuing Labor on costs to remove election signage, but no edict to pay